Drug Shortage Report for BEZALIP SR
| Report ID | 128643 |
| Drug Identification Number | 02083523 |
| Brand name | BEZALIP SR |
| Common or Proper name | Bezalip |
| Company Name | ALLERGAN INC |
| Market Status | MARKETED |
| Active Ingredient(s) | BEZAFIBRATE |
| Strength(s) | 400MG |
| Dosage form(s) | TABLET (EXTENDED-RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | 30 tabs |
| ATC code | C10AB |
| ATC description | LIPID MODIFYING AGENTS, PLAIN |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2020-11-16 |
| Estimated end date | 2020-12-04 |
| Actual end date | 2020-12-02 |
| Shortage status | Resolved |
| Updated date | 2020-12-03 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | Company contact information; Telephone number: 800-668-6424 Email address: MR-GENERAL_INQUIRY@allergan.com Website address: allergan.ca Postal address: 500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2020-12-03 | English | Compare |
| v4 | 2020-12-02 | French | Compare |
| v3 | 2020-12-02 | English | Compare |
| v2 | 2020-11-19 | French | Compare |
| v1 | 2020-11-19 | English | Compare |
Showing 1 to 5 of 5